Estrogen-induced redox sensitive Id3 signaling controls the growth of vascular cells

Atherosclerosis

Volumn 198, Issue 1, 2008, Pages 12-21

  Felty, Quentin ^a   Porther, Nicole ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Angiogenesis; Estrogen; Id3; Redox; Vasculoproliferative disorders

Indexed keywords

ACETYLCYSTEINE; CATALASE; COLCHICINE; CYTOCHALASIN D; EBSELEN; ESTROGEN; HYDROGEN PEROXIDE; INHIBITOR OF DIFFERENTIATION 3; MANGANESE SUPEROXIDE DISMUTASE; MATRIGEL; SMALL INTERFERING RNA; SUPEROXIDE;

ACTIN FILAMENT; ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANTIOXIDANTS; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; DERMIS; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ESTRADIOL; FIBROBLASTS; GENE EXPRESSION; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; LAMININ; NEOPLASM PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEOGLYCANS; SIGNAL TRANSDUCTION; UMBILICAL VEINS;

EID: 40949153028     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.048     Document Type: Article

References (40)

1. Subbiah M.T. Mechanisms of cardioprotection by estrogens. Proc Soc Exp Biol Med 217 (1998) 23-29
2. Rossouw J.E. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones. Maturitas 51 (2005) 51-63
3. The Coronary Drug Project. Initial findings leading to modifications of its research protocol. JAMA 214 (1970) 1303-1313
4. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. JAMA 226 (1973) 652-657
5. Howard B.V., Hsia J., Ouyang P., et al. Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance. Circulation 110 (2004) 201-206
6. Cox R.L., and Crawford E.D. Estrogens in the treatment of prostate cancer. J Urol 154 (1995) 1991-1998
7. Tivesten A., Hulthe J., Wallenfeldt K., et al. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. J Clin Endocrinol Metab 91 (2006) 4433-4437
8. Ridker P.M., Hennekens C.H., Rifai N., Buring J.E., and Manson J.E. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100 (1999) 713-716
9. Kluft C., Leuven J.A., Helmerhorst F.M., and Krans H.M. Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. Vascul Pharmacol 39 (2002) 149-154
10. Channon K.M. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med 14 (2004) 323-327
11. White R.E., Han G., Dimitropoulou C., et al. Estrogen-induced contraction of coronary arteries is mediated by superoxide generated in vascular smooth muscle. Am J Physiol Heart Circ Physiol 289 (2005) H1468-H1475
12. Benditt E.P., and Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 70 (1973) 1753-1756
13. Boehm M., and Nabel E.G. The cell cycle and cardiovascular diseases. Prog Cell Cycle Res 5 (2003) 19-30
14. Forrest S., and McNamara C. Id family of transcription factors and vascular lesion formation. Arterioscler Thromb Vasc Biol 24 (2004) 2014-2020
15. Felty Q. Estrogen-induced DNA synthesis in vascular endothelial cells is mediated by ROS signaling. BMC Cardiovasc Disord 6 (2006) 16
16. Mueller C., Baudler S., Welzel H., Bohm M., and Nickenig G. Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth. Circulation 105 (2002) 2423-2428
17. Matsumura M.E., Li F., Berthoux L., et al. Vascular injury induces posttranscriptional regulation of the Id3 gene: cloning of a novel Id3 isoform expressed during vascular lesion formation in rat and human atherosclerosis. Arterioscler Thromb Vasc Biol 21 (2001) 752-758
18. Nickenig G., Baudler S., Muller C., et al. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J 16 (2002) 1077-1086
19. Forrest S.T., Barringhaus K.G., Perlegas D., Hammarskjold M.L., and McNamara C.A. Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation. J Biol Chem 279 (2004) 32897-32903
20. Soares R., Guo S., Gartner F., Schmitt F.C., and Russo J. 17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis 6 (2003) 271-281
21. Friis T., Hansen A.B., Houen G., and Engel A.M. Influence of angiogenesis inhibitors on endothelial cell morphology in vitro. APMIS 114 (2006) 211-224
22. Kubota Y., Kleinman H.K., Martin G.R., and Lawley T.J. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107 (1988) 1589-1598
23. Riccioni T., Cirielli C., Wang X., Passaniti A., and Capogrossi M.C. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo. Gene Ther 5 (1998) 747-754
24. Ramalingam R., Worgall S., Rafii S., and Crystal R.G. Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1(-)E4(+) adenovirus gene transfer vectors. Mol Ther 2 (2000) 381-386
25. Harfouche R, bdel-Malak NA, Brandes RP, et al. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J, 2005.
26. Cai H. Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences. Cardiovasc Res, 2005.
27. Felty Q., and Roy D. Estrogen, mitochondria, and growth of cancer and non-cancer cells. J Carcinog 4 (2005) 1
28. Ali M.H., Pearlstein D.P., Mathieu C.E., and Schumacker P.T. Mitochondrial requirement for endothelial responses to cyclic strain: implications for mechanotransduction. Am J Physiol Lung Cell Mol Physiol 287 (2004) L486-L496
29. Felty Q., Xiong W.C., Sun D., et al. Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry 44 (2005) 6900-6909
30. Matsumura T., Wolff K., and Petzelbauer P. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 158 (1997) 3408-3416
31. Donovan D., Brown N.J., Bishop E.T., and Lewis C.E. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 4 (2001) 113-121
32. Felty Q, Singh KP, Roy D. Estrogen-induced G(1)/S transition of G(0)-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene, 2005.
33. Forrest S.T., Taylor A.M., Sarembock I.J., Perlegas D., and McNamara C.A. Phosphorylation regulates Id3 function in vascular smooth muscle cells. Circ Res 95 (2004) 557-559
34. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 3 (2002) 1129-1134
35. Ozaki M., Kawashima S., Yamashita T., et al. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest 110 (2002) 331-340
36. Behl C., Skutella T., Lezoualc'h F., et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51 (1997) 535-541
37. Kahlon R., Shapero J., and Gotlieb A.I. Angiogenesis in atherosclerosis. Can J Cardiol 8 (1992) 60-64
38. Arteaga E., Villaseca P., Bianchi M., et al. Raloxifene is a better antioxidant of low-density lipoprotein than estradiol or tamoxifen in postmenopausal women in vitro. Menopause 10 (2003) 142-146
39. Felty Q., and Roy D. Potential use of J774A.1 macrophage cells to biomonitor estrogenic activity in non-estrogen dependent tissue. In Vitro Cell Dev Biol 38 (2002) 13
40. Roy D., and Cai Q. Estrogen, immunoactivation, gene damage, and development of breast, endometrial, ovarian, prostate, and testicular cancers. Recent Res Devel Steroid Biochem Mol Biol 3 (2002) 1-32